Arch Chemicals, Inc. Declares Quarterly Dividend

Catch up with NBC News Clone on today's hot topic: Wbna41298744 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

NORWALK, Conn., Jan. 27, 2011 (GLOBE NEWSWIRE) -- The Arch Chemicals, Inc. Board of Directors on January 27, 2011 declared a quarterly dividend of 20-cents on each share of Arch Chemicals (NYSE:ARJ) common stock. The dividend is payable on March 15, 2011 to shareholders of record at the close of business on February 15, 2011.

NORWALK, Conn., Jan. 27, 2011 (GLOBE NEWSWIRE) -- The Arch Chemicals, Inc. Board of Directors on January 27, 2011 declared a quarterly dividend of 20-cents on each share of Arch Chemicals (NYSE:ARJ) common stock. The dividend is payable on March 15, 2011 to shareholders of record at the close of business on February 15, 2011.

Headquartered in Norwalk, Connecticut (USA), Arch Chemicals, Inc. is a global Biocides company with annual sales of over $1 billion. Arch and its subsidiaries provide innovative, chemistry-based and related solutions to selectively destroy and control the growth of harmful microbes. The Company's businesses are concentrated in water treatment, hair and skin care products, wood treatment, preservation and protection applications, such as for paints and building products, and health and hygiene applications. Arch Chemicals operates in two segments: Biocides Products and Performance Products. Together with its subsidiaries, Arch has approximately 3,000 employees and manufacturing and customer-support facilities in North and South America, Europe, Asia, Australia and Africa.

CONTACT: Investor contact: Mark E. Faford (203) 229-3820 mefaford@archchemicals.com Press contact: Dale N. Walter (203) 229-3033 dnwalter@archchemicals.com
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone